2023 Q2 Form 10-Q Financial Statement

#000010726323000013 Filed on May 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $2.483B $3.081B $2.524B
YoY Change -0.28% 22.07% -3.37%
Cost Of Revenue $465.0M $607.0M $833.0M
YoY Change -48.16% -27.13% -12.59%
Gross Profit $2.018B $2.474B $1.691B
YoY Change 26.68% 46.3% 1.93%
Gross Profit Margin 81.27% 80.3% 67.0%
Selling, General & Admin $641.0M $176.0M $154.0M
YoY Change 300.63% 14.29% 25.2%
% of Gross Profit 31.76% 7.11% 9.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $515.0M $506.0M $498.0M
YoY Change 1.78% 1.61% 13.7%
% of Gross Profit 25.52% 20.45% 29.45%
Operating Expenses $1.147B $176.0M $154.0M
YoY Change 616.88% 14.29% 25.2%
Operating Profit $871.0M $1.360B $654.0M
YoY Change 84.53% 107.95% -11.5%
Interest Expense -$133.0M $294.0M $286.0M
YoY Change -147.33% 2.8% -2.72%
% of Operating Profit -15.27% 21.62% 43.73%
Other Income/Expense, Net $19.00M $20.00M $5.000M
YoY Change 216.67% 300.0% -350.0%
Pretax Income $756.0M $1.241B $510.0M
YoY Change 108.84% 143.33% -11.46%
Income Tax $175.0M $284.0M $118.0M
% Of Pretax Income 23.15% 22.88% 23.14%
Net Earnings $460.0M $927.0M $380.0M
YoY Change 15.0% 143.95% -10.8%
Net Earnings / Revenue 18.53% 30.09% 15.06%
Basic Earnings Per Share $0.38 $0.76 $0.31
Diluted Earnings Per Share $0.37 $0.76 $0.31
COMMON SHARES
Basic Shares Outstanding 1.218B shares 1.219B shares 1.217B shares
Diluted Shares Outstanding 1.220B shares 1.226B shares 1.221B shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $551.0M $477.0M $604.0M
YoY Change 314.29% -21.03% -46.36%
Cash & Equivalents $551.0M $477.0M $604.0M
Short-Term Investments
Other Short-Term Assets $467.0M $269.0M $272.0M
YoY Change 113.24% -1.1% 60.95%
Inventory $259.0M $244.0M $201.0M
Prepaid Expenses
Receivables $1.362B $1.524B $1.973B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.639B $2.757B $3.154B
YoY Change -30.31% -12.59% 26.31%
LONG-TERM ASSETS
Property, Plant & Equipment $32.35B $32.10B $29.19B
YoY Change 9.06% 9.97% 0.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.046B $5.067B $5.107B
YoY Change -1.37% -0.78% -0.43%
Other Assets $1.421B $1.357B $1.324B
YoY Change 4.56% 2.49% 10.52%
Total Long-Term Assets $46.39B $46.18B $42.90B
YoY Change 5.98% 7.66% 0.3%
TOTAL ASSETS
Total Short-Term Assets $2.639B $2.757B $3.154B
Total Long-Term Assets $46.39B $46.18B $42.90B
Total Assets $49.03B $48.94B $46.05B
YoY Change 3.09% 6.27% 1.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.146B $1.258B $1.584B
YoY Change -54.09% -20.58% 194.42%
Accrued Expenses $1.218B $955.0M $1.099B
YoY Change -14.65% -13.1% 28.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $2.877B $1.627B $1.625B
YoY Change 228.42% 0.12% -24.14%
Total Short-Term Liabilities $5.384B $4.020B $4.308B
YoY Change -7.78% -6.69% 21.87%
LONG-TERM LIABILITIES
Long-Term Debt $21.53B $22.79B $20.80B
YoY Change 3.52% 9.54% -1.38%
Other Long-Term Liabilities $4.575B $4.631B $4.399B
YoY Change 0.9% 5.27% 7.37%
Total Long-Term Liabilities $26.11B $27.42B $25.20B
YoY Change 3.05% 8.79% 0.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.384B $4.020B $4.308B
Total Long-Term Liabilities $26.11B $27.42B $25.20B
Total Liabilities $37.35B $37.15B $34.73B
YoY Change 2.8% 6.96% 3.5%
SHAREHOLDERS EQUITY
Retained Earnings -$12.98B -$12.90B -$13.38B
YoY Change -3.82% -3.61% 4.31%
Common Stock $25.79B $25.77B $25.73B
YoY Change 0.16% 0.17% 0.37%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.180B $1.124B $1.041B
YoY Change 13.35% 7.97% 0.0%
Treasury Stock Shares 35.00M shares
Shareholders Equity $11.68B $11.79B $11.32B
YoY Change
Total Liabilities & Shareholders Equity $49.03B $48.94B $46.05B
YoY Change 3.09% 6.27% 1.74%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $460.0M $927.0M $380.0M
YoY Change 15.0% 143.95% -10.8%
Depreciation, Depletion And Amortization $515.0M $506.0M $498.0M
YoY Change 1.78% 1.61% 13.7%
Cash From Operating Activities $1.377B $1.514B $1.082B
YoY Change 25.41% 39.93% 18.25%
INVESTING ACTIVITIES
Capital Expenditures $624.0M $545.0M $291.0M
YoY Change -295.0% 87.29% 11.92%
Acquisitions $1.056B $0.00
YoY Change
Other Investing Activities -$25.00M $3.000M $4.000M
YoY Change -97.43% -25.0% 300.0%
Cash From Investing Activities -$649.0M -$1.639B -$360.0M
YoY Change -49.77% 355.28% 40.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $37.00M
YoY Change 1133.33%
Debt Paid & Issued, Net $7.000M $1.256B
YoY Change -99.44% 25020.0%
Cash From Financing Activities -654.0M $450.0M -$1.798B
YoY Change 136.1% -125.03% -651.53%
NET CHANGE
Cash From Operating Activities 1.377B $1.514B $1.082B
Cash From Investing Activities -649.0M -$1.639B -$360.0M
Cash From Financing Activities -654.0M $450.0M -$1.798B
Net Change In Cash 74.00M $325.0M -$1.076B
YoY Change -115.71% -130.2% -209.35%
FREE CASH FLOW
Cash From Operating Activities $1.377B $1.514B $1.082B
Capital Expenditures $624.0M $545.0M $291.0M
Free Cash Flow $753.0M $969.0M $791.0M
YoY Change -46.9% 22.5% 20.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000107263
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-4174
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
WILLIAMS COMPANIES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
73-0569878
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Williams Center
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Tulsa
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
OK
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
74172-0172
CY2023Q1 dei City Area Code
CityAreaCode
800
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
945-5426
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $1.00 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
WMB
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1218187114 shares
CY2023Q1 us-gaap Revenues
Revenues
3081000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2524000000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
463000000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
394000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
506000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
498000000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176000000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
154000000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
31000000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
9000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
1721000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
1870000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1360000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
654000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
136000000 usd
CY2023Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8000000 usd
CY2022Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1000000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
304000000 usd
CY2022Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
289000000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
10000000 usd
CY2022Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
3000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1241000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
510000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
118000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
957000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
30000000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
927000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
927000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
380000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
380000000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1000000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
926000000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
379000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1219465000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1216940000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1225781000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1221279000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
957000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
7000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
20000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
3000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-1000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-2000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
978000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
397000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
30000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
12000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
948000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
385000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
477000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152000000 usd
CY2023Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1530000000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2729000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1524000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2723000000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
244000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
320000000 usd
CY2023Q1 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
243000000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
323000000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
269000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
279000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2757000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3797000000 usd
CY2023Q1 us-gaap Investments
Investments
5067000000 usd
CY2022Q4 us-gaap Investments
Investments
5065000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
49546000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47057000000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17451000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16168000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32095000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30889000000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7660000000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
7363000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1357000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1319000000 usd
CY2023Q1 us-gaap Assets
Assets
48936000000 usd
CY2022Q4 us-gaap Assets
Assets
48433000000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1258000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2327000000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
180000000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
316000000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
955000000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1270000000 usd
CY2023Q1 us-gaap Commercial Paper
CommercialPaper
0 usd
CY2022Q4 us-gaap Commercial Paper
CommercialPaper
350000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1627000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
627000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4020000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4890000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
22785000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
21927000000 usd
CY2023Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
3177000000 usd
CY2022Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
2887000000 usd
CY2023Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
4631000000 usd
CY2022Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
4684000000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
35000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
35000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
35000000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
35000000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1470000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1470000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1256000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1253000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1256000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1253000000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24516000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
24542000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12895000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13271000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24000000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
37000000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
35000000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1124000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1050000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11785000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11485000000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
2538000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
2560000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14323000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14045000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48936000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48433000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14045000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
957000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
21000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4475
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
546000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
54000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-23000000 usd
CY2023Q1 wmb Contributions From Noncontrolling Interests
ContributionsFromNoncontrollingInterests
3000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
74000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
6000000 usd
CY2023Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
278000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14323000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
14101000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.425
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
518000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
37000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
29000000 usd
CY2022Q1 wmb Contributions From Noncontrolling Interests
ContributionsFromNoncontrollingInterests
3000000 usd
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
4000000 usd
CY2022Q1 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-130000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
13971000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
957000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
506000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
498000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
283000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
115000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
136000000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
208000000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
212000000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
327000000 usd
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives And Commodity Contracts
UnrealizedGainLossOnDerivativesAndCommodityContracts
-123000000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
18000000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
17000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
21000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-1269000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
3000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-178000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4000000 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
65000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1017000000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-138000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-318000000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-149000000 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-82000000 usd
CY2022Q1 us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-101000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-40000000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-67000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1514000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1082000000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
-352000000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Commercial Paper
ProceedsFromRepaymentsOfCommercialPaper
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1502000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3000000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1256000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
74000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
546000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
518000000 usd
CY2023Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
54000000 usd
CY2022Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
37000000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3000000 usd
CY2022Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3000000 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8000000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-30000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
450000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1798000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
545000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
291000000 usd
CY2023Q1 wmb Payments To Retire Proceeds From Sale Of Property Plant And Equipment
PaymentsToRetireProceedsFromSaleOfPropertyPlantAndEquipment
7000000 usd
CY2022Q1 wmb Payments To Retire Proceeds From Sale Of Property Plant And Equipment
PaymentsToRetireProceedsFromSaleOfPropertyPlantAndEquipment
6000000 usd
CY2023Q1 us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
11000000 usd
CY2022Q1 us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
-3000000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1056000000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
39000000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
56000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1639000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-360000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
325000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1076000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1680000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
477000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
604000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
484000000 usd
CY2022Q1 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
260000000 usd
CY2023Q1 wmb Increase Decrease In Accounts Payable And Accrued Liabilities Related To Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToCapitalExpendituresIncurredButNotYetPaid
-61000000 usd
CY2022Q1 wmb Increase Decrease In Accounts Payable And Accrued Liabilities Related To Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRelatedToCapitalExpendituresIncurredButNotYetPaid
-31000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
545000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
291000000 usd
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1500000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
74000000 usd
CY2023Q1 wmb Stock Repurchase Program Cumulative Amount Purchased
StockRepurchaseProgramCumulativeAmountPurchased
83000000 usd
CY2023Q1 us-gaap Revenues
Revenues
3081000000 usd
CY2023Q1 us-gaap Revenues
Revenues
3081000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
927000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
927000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2524000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
380000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
380000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3119000000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1997000000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
-2035000000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4102000000 usd
CY2022Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1556000000 usd
CY2022Q1 us-gaap Revenue Not From Contract With Customer Other
RevenueNotFromContractWithCustomerOther
-3134000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2524000000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
29000000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
22000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
43000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
55000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
30000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
41000000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
42000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
36000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1043000000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1126000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-29000000 usd
CY2022Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
-29000000 usd
CY2023Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
2000000 usd
CY2022Q1 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
2000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
-5000000 usd
CY2022Q1 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
0 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
69000000 usd
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
64000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1010000000 usd
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1093000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
98000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2887000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
124000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3647000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
122000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3363000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
107000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2837000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
101000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2564000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
458000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
15096000000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1010000000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
30394000000 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
1524000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2723000000 usd
CY2022Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
21000000 usd
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1000000 usd
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1000000 usd
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1000000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000000 usd
CY2023Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
237000000 usd
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
94000000 usd
CY2023Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
46000000 usd
CY2023Q1 us-gaap Additional Collateral Aggregate Fair Value
AdditionalCollateralAggregateFairValue
7000000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
283000000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
115000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
118000000 usd
CY2023Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
120000000 usd
CY2023Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
40000000 usd
CY2023Q1 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
511000000 usd
CY2023Q1 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
631000000 usd
CY2022Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
1034000000 usd
CY2022Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
1236000000 usd
CY2023Q1 us-gaap Derivative Assets
DerivativeAssets
256000000 usd
CY2023Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
453000000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
334000000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
776000000 usd
CY2023Q1 wmb Modified Ebitda Earnings Loss
ModifiedEBITDAEarningsLoss
2130000000 usd
CY2022Q1 wmb Modified Ebitda Earnings Loss
ModifiedEBITDAEarningsLoss
1393000000 usd
CY2023Q1 wmb Asset Retirement Obligation Accretion Expense For Nonregulated Operations
AssetRetirementObligationAccretionExpenseForNonregulatedOperations
15000000 usd
CY2022Q1 wmb Asset Retirement Obligation Accretion Expense For Nonregulated Operations
AssetRetirementObligationAccretionExpenseForNonregulatedOperations
11000000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
506000000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
498000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
147000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
136000000 usd
CY2023Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8000000 usd
CY2022Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1000000 usd
CY2023Q1 wmb Proportional Modified Ebitda Equity Method Investments
ProportionalModifiedEBITDAEquityMethodInvestments
229000000 usd
CY2022Q1 wmb Proportional Modified Ebitda Equity Method Investments
ProportionalModifiedEBITDAEquityMethodInvestments
225000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
294000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
286000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
284000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
118000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
957000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
392000000 usd
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
18000000 usd
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q1 us-gaap Revenues
Revenues
3081000000 usd
CY2022Q1 us-gaap Revenues
Revenues
2524000000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000107263-23-000013-index-headers.html Edgar Link pending
0000107263-23-000013-index.html Edgar Link pending
0000107263-23-000013.txt Edgar Link pending
0000107263-23-000013-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wmb-20230331.htm Edgar Link pending
wmb-20230331.xsd Edgar Link pending
wmb_20230331xex101.htm Edgar Link pending
wmb_20230331xex102.htm Edgar Link pending
wmb_20230331xex311.htm Edgar Link pending
wmb_20230331xex312.htm Edgar Link pending
wmb_20230331xex32.htm Edgar Link pending
wmb-20230331_def.xml Edgar Link unprocessable
wmb-20230331_cal.xml Edgar Link unprocessable
wmb-20230331_lab.xml Edgar Link unprocessable
wmb-20230331_pre.xml Edgar Link unprocessable
wmb-20230331_htm.xml Edgar Link completed